Results 61 to 70 of about 19,821,917 (190)
Safety of endovascular thrombectomy in patients receiving non-vitamin K antagonist oral anticoagulants [PDF]
Background and Purpose—Prospective data on the safety of endovascular thrombectomy in acute stroke patients on non– vitamin K antagonist oral anticoagulants are lacking. Methods—Prospective multicenter observational study.
Khan, S +16 more
core +1 more source
ABSTRACT Background Rotational atherectomy (RA) has undergone considerable technical modernization in recent years. This study evaluated whether RA performed in the contemporary era was associated with superior cardiovascular outcomes compared with the traditional era. Aims To compare the clinical characteristics and cardiovascular outcomes of patients
Ravi Vazirani +15 more
wiley +1 more source
Objectives The evaluation of the "net clinical benefit" allows an integrated assessment of both the anti-ischemic and the prohemorrhagic effects of non-vitamin K antagonist oral anticoagulants compared with warfarin, and - in the absence of direct ...
DE CATERINA, Raffaele +2 more
core +1 more source
Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K-1) in severe acute liver disease [PDF]
Background/Aims: In patients with severe acute liver dysfunction, i.v. phylloquinone (vitamin K-1) may be given to exclude vitamin K deficiency, rather than impaired hepatic synthesis of coagulation factors alone, as the cause of the coagulopathy ...
Pereira, SP +13 more
core +1 more source
Although known for its importance in the coagulation cascade, vitamin K has other functions. It is an essential vitamin for bone health, taking part in the carboxylation of many bone-related proteins, regulating genetic transcription of osteoblastic ...
Celia Rodríguez-Olleros Rodríguez +1 more
doaj +1 more source
Dicloxacillin is a penicillinase‐resistant beta‐lactam antibiotic and potent activator of the Pregnane X receptor (PXR), known to induce CYP2C9, CYP2C19, and CYP3A4 activity. Clinical data suggest it reduces anticoagulation in warfarin‐treated patients and increases the risk of thromboembolic events.
Chanan Shaul +5 more
wiley +1 more source
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen +4 more
wiley +1 more source
MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio +10 more
wiley +1 more source
Pooled characteristics of patients suffering acute cerebral ischemic events while taking non-vitamin K antagonist oral anticoagulants (N = 12247).
Simon Jung (672063) +7 more
core +1 more source
Anticoagulation therapy and the use of non-vitamin K antagonist oral anticoagulants in the elderly
Anticoagulation indications do not differ between elderly and younger patients. However due to the changes with ageing some anticoagulants may increase the risk of bleeding. Therefore a dose adjustment might be needed for some anticoagulant drugs. Non-vitamin K antagonists are as safe and effective as vitamin K antagonists in the elderly.
openaire +3 more sources

